BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 84095)

  • 1. [Endocrine ophthalmopathy in Graves disease during antithyroid drug therapy (author's transl)].
    Wuttke H; Schlieter D; Krück F
    Klin Wochenschr; 1979 Jan; 57(2):69-74. PubMed ID: 84095
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stimulation of endogenous TSH secretion and endocrine orbitopathy].
    Wuttke H; Schlieter D
    Med Klin; 1980 Aug; 75(18):658-62. PubMed ID: 6158667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperthyroidism].
    Bürgi U; Maurer P
    Schweiz Rundsch Med Prax; 1994 Jan; 83(3):61-4. PubMed ID: 7507596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves disease.
    Skuza KA; Sills IN; Stene M; Rapaport R
    J Pediatr; 1996 Feb; 128(2):264-8. PubMed ID: 8636826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of patients with thyrotoxicosis of childbearing age (author's transl)].
    Momotani N; Hamada N; Ban Y; Mimura T; Nishikawa Y
    Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1148-58. PubMed ID: 73481
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of effects of antithyroid drug treatment based mainly on the TRH test].
    Irie M; Enomoto K; Inoue K; Enomoto H; Nukii T
    Horumon To Rinsho; 1974 Feb; 22(2):249-50. PubMed ID: 4136015
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH; Richards AR; Addison GM; Owen GM
    Lancet; 1974 Nov; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the management of hyperthyroidism and hypothyroidism.
    Woeber KA
    Arch Fam Med; 2000 Aug; 9(8):743-7. PubMed ID: 10927715
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
    N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early histological changes of the thyroid gland sway the prognosis of juvenile thyrotoxicosis treated with antithyroid therapy (author's transl)].
    Takata I; Saida K; Suzuki Y; Sato T
    Horumon To Rinsho; 1979 Sep; 27(9):938-42. PubMed ID: 93525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
    Takamatsu J
    Nihon Naibunpi Gakkai Zasshi; 1983 Mar; 59(3):295-303. PubMed ID: 6190686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].
    Lorcy Y; Heim J; Auvray E; Allannic H
    Ann Endocrinol (Paris); 1979; 40(4):441-2. PubMed ID: 117739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in serum T3, T4 and TSH before and after the T3-suppression test in patients treated for Graves' disease (author's transl)].
    Tamai H; Suematsu H; Esaki M; Kurakawa N; Aoki H
    Nihon Naibunpi Gakkai Zasshi; 1977 Jan; 53(1):17-27. PubMed ID: 72007
    [No Abstract]   [Full Text] [Related]  

  • 17. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of hyperthyroidism (author's transl)].
    Baumann G
    Ther Umsch; 1973 Oct; 30(10):734-9. PubMed ID: 4126863
    [No Abstract]   [Full Text] [Related]  

  • 19. Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.
    Liu X; Shi B; Li H
    Ann Endocrinol (Paris); 2015 Dec; 76(6):679-83. PubMed ID: 26514949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
    Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.